Table 1 Demographic and clinical characteristics for DC Cohort participants whose samples were sequenced and passed filtering criteria.
Total N = 68 | |
|---|---|
Age Range | |
20–29 yrs | 7 |
30–49 yrs | 31 |
50–69 yrs | 30 |
Median Age (yrs, IQR) | 46.3 (23.5, 66.8) |
Race/Ethnicity | |
Non-Hispanic Black | 56 (82.4%) |
Non-Hispanic White | 4 (5.9%) |
Hispanic | 5 (7.4%) |
Unknown | 3 (4.4%) |
Sex at Birth | |
Male | 47 (69.1%) |
Female | 21 (30.9%) |
Gender | |
Male | 45 (66.2%) |
Female | 21 (30.8%) |
Transgender | 1 (1.5%) |
Unknown | 1 (1.5%) |
Country of Birth | |
US | 59 (86.8%) |
Non-US | 6 (8.8%) |
Unknown | 3 (4.4%) |
State of Residence | |
DC | 55 (80.9%) |
MD | 10 (14.8%) |
VA | 3 (4.4%) |
HIV-1 Risk Factor | |
MSM | 24 (35.3%) |
IDU | 6 (8.8%) |
HRH | 27 (39.7%) |
UNK | 11 (16.2%) |
Co-infectionsa | |
Syphilis | 1 (1.4%) |
Hepatitis B | 1 (1.4%) |
Hepatitis C | 1 (1.4%) |
Median Duration of Infection (yrs, IQR) | 12.2 (5, 18) |
Median CD4 count (cells/ul, IQR) | 419.3 (69.5, 586) |
Viral Load Range (copies/ml)b | |
<200 | 21 (30.9%) |
200–399 | 5 (7.4%) |
400–9,999 | 14 (20.6%) |
>10,000 | 3 (4.4%) |
Unknown | 25 (36.8%) |
ART Exposure | |
Experienced | 61 (89.7%) |
Naïve | 7 (10.3%) |
ART Regimen Type | |
Multiple-Class | 50 (73.5%) |
Dual-Class | 2 (2.9%) |
Unknown | 16 (23.5%) |
Amplicon Presence | |
Before Quality Filtering | |
PR/RT | 68 (100%) |
int | 68 (100%) |
env | 62 (91.2%) |
After Quality Filtering | |
PR/RT | 62 (91.2%) |
int | 62 (91.2%) |
env | 47 (69.1%) |
